Inhibition of the gap junction protein connexin 43, essential for astrocyte–tumor interactions, can effectively suppress metastatic growth in mouse models [67,68] suggesting that targeting astrocytes and their gap junctions with tumor cells could have therapeutic potential in treating brain metastasis. The gene discussed is GJA1; the disease is neoplasm.